IndiaTickerLatest filing: Investor Presentation - Beta Drugs Limited
ObservedCompany dossier
Beta Drugs
NSE:BETA · ISIN INE351Y01019
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Beta Drugs
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest ownership: promoter group 59.10% and public 40.90% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Investor Presentation - Beta Drugs Limited
NSE · investor presentation
Observed
Source filing Reply to Clarification- Financial results - Beta Drugs Limited
NSE · financial results
Observed
Source filing Copy of Newspaper Publication - Beta Drugs Limited
NSE · exchange filing
Observed
Source filing Outcome of Board Meeting - Beta Drugs Limited
NSE · financial results
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 59.10%
- Public
- 40.90%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL